Preventing and reversing neuroinflammatory brain damage using local expansion of regulatory T cells

Project Information

TreatBrainDamage

Grant agreement ID: 899863

DOI

10.3030/899863

Project closed

EC signature date 9 May 2020

Start date 1 September 2020

End date 28 February 2022

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

No data

EU contribution

€ 150 000,00

Coordinated by

THE BABRAHAM INSTITUTE
United Kingdom

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Astrocyte-targeted gene delivery of interleukin 2 specifically increases brain-resident regulatory T cell numbers and protects against pathological neuroinflammation

Author(s): "Lidia Yshii # 1 2 3, Emanuela Pasciuto # 1 2 3, Pascal Bielefeld # 4 5, Loriana Mascali 1 2, Pierre Lemaitre 1 2, Marika Marino 1 3, James Dooley 5, Lubna Kouser 5, Stijn Verschoren 1 3, Vasiliki Lagou 1 2, Hannelore Kemps 6, Pascal Gervois 6, Antina de Boer 1 3, Oliver T Burton 5, Jérôme Wahis 1 3, Jens Verhaert 1 3, Samar H K Tareen 5, Carlos P Roca 5, Kailash Singh 5, Carly E Whyte 5, Axelle"
Published in: Nature Immunology, Issue Online ahead of print, 2022, ISSN 1529-2908
Publisher: Nature Publishing Group
DOI: 10.1038/s41590-022-01208-z